EP4182026 - CANNABIDIOL (CBD) BASED COMPOSITION AND METHOD FOR TREATING PAIN [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 21.04.2023 Database last updated on 12.11.2024 | |
Former | The international publication has been made Status updated on 21.01.2022 | Most recent event Tooltip | 05.09.2024 | New entry: Additional fee for renewal fee: despatch of communication + time limit | Applicant(s) | For all designated states India Globalization Capital, Inc. 10224 Falls Road Potomac, MD 20854 / US | [2023/21] | Inventor(s) | 01 /
MUKUNDA, Ramachandra Potomac, Maryland 20854 / US | 02 /
RAO, Jagadeesh Sridhara Ashburn, Virginia 20147 / US | [2023/21] | Representative(s) | Script Intellectual Property LLP Suite J, Anchor House School Close Chandlers Ford Eastleigh, Hampshire SO53 4DY / GB | [N/P] |
Former [2023/21] | McQueen, Andrew Peter Miltons IP - Europe 5th Floor, Broad Quay House Prince Street Bristol BS1 4DJ / GB | Application number, filing date | 21843338.1 | 19.07.2021 | [2023/21] | WO2021US42243 | Priority number, date | US202063053558P | 17.07.2020 Original published format: US 202063053558 P | [2023/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022016160 | Date: | 20.01.2022 | Language: | EN | [2022/03] | Type: | A1 Application with search report | No.: | EP4182026 | Date: | 24.05.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.01.2022 takes the place of the publication of the European patent application. | [2023/21] | Search report(s) | International search report - published on: | US | 20.01.2022 | (Supplementary) European search report - dispatched on: | EP | 03.09.2024 | Classification | IPC: | A61P29/00, A61K31/352, A61K36/886, A61K36/534, A61K36/67, A61K31/4172, A61K31/05, A61K31/125, A61K31/165, A61K31/355, A61K31/375, A61K31/417, A61K31/60, A61K36/185, A61K9/00 | [2024/40] | CPC: |
A61P29/00 (EP);
A61K31/658 (US);
A61K31/05 (EP,US);
A61K31/125 (EP,US);
A61K31/165 (EP,US);
A61K31/352 (EP);
A61K31/355 (EP,US);
A61K31/375 (EP,US);
A61K31/417 (EP,US);
A61K31/60 (EP,US);
A61K36/185 (EP);
A61K36/67 (EP,US);
A61K36/886 (EP,US);
A61K47/10 (EP,US);
A61K47/18 (EP,US);
A61K47/32 (EP,US);
A61K9/0014 (EP);
A61K9/06 (US);
A61K9/7023 (US);
A61P23/02 (US);
A61K47/14 (EP);
A61K47/24 (EP)
(-)
| C-Set: |
A61K31/05, A61K2300/00 (EP);
A61K31/125, A61K2300/00 (EP);
A61K31/165, A61K2300/00 (EP);
A61K31/352, A61K2300/00 (EP);
A61K31/355, A61K2300/00 (EP);
A61K31/375, A61K2300/00 (EP);
A61K31/417, A61K2300/00 (EP);
A61K31/60, A61K2300/00 (EP);
A61K36/185, A61K2300/00 (EP);
A61K36/67, A61K2300/00 (EP); |
Former IPC [2023/21] | A61P29/00, A61K31/352, A61K36/886, A61K36/534, A61K36/67, A61K31/4172 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/21] | Title | German: | ZUSAMMENSETZUNG AUF DER BASIS VON CANNABIDIOL (CBD) UND VERFAHREN ZUR BEHANDLUNG VON SCHMERZEN | [2023/21] | English: | CANNABIDIOL (CBD) BASED COMPOSITION AND METHOD FOR TREATING PAIN | [2023/21] | French: | COMPOSITION À BASE DE CANNABIDIOL (CBD) ET MÉTHODE DE TRAITEMENT DE LA DOULEUR | [2023/21] | Entry into regional phase | 16.02.2023 | National basic fee paid | 16.02.2023 | Search fee paid | 16.02.2023 | Designation fee(s) paid | 16.02.2023 | Examination fee paid | Examination procedure | 16.02.2023 | Examination requested [2023/21] | 28.08.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 19.07.2023 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.07.2024 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US2018042890 (SINAI ALON [IL], et al); | [XI]WO2020012480 (INNOCAN PHARMA LTD [IL]); | [A]US2020138737 (HETHERINGTON MARK ANDREW [CA], et al); | [XP]WO2020264052 (HEMPVANA LLC [US], et al); | International search | [A]US2019111093 (SIURKUS JUOZAS [LT], et al); | [XY]WO2019178360 (POVIVA TEA LLC [US]); | [A]WO2020009950 (COMPANION SCIENCES LLC [US]); | [Y]WO2020012480 (INNOCAN PHARMA LTD [IL]); | [Y]US2020138737 (HETHERINGTON MARK ANDREW [CA], et al); | [XP]WO2020232530 (CANOPY GROWTH CORP [CA]); | [AP]US2020384051 (GOWEY BRANDIE [US]); | [XP]US2021015836 (LAROSA TONY [US], et al) |